Hermann Brustmann Selected Research

Hermann Brustmann Research Topics

Disease

18	Neoplasms (Cancer) 03/2015 - 01/2002
11	Carcinoma (Carcinomatosis) 07/2008 - 01/2002
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2012 - 08/2002
5	Serous Cystadenoma 07/2008 - 01/2002
3	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 05/2013 - 11/2011
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2015 - 04/2015
2	Prostatitis 12/2015 - 04/2015
2	Endometrial Neoplasms (Endometrial Cancer) 01/2012 - 04/2005
2	Endometrial Hyperplasia 01/2012 - 04/2005
2	Hyperplasia 01/2007 - 04/2005
2	Neoplasms, Cystic, Mucinous, and Serous 09/2005 - 01/2004
2	Adenocarcinoma 04/2005 - 10/2004
1	Inflammation (Inflammations) 12/2015
1	Calculi (Calculus) 12/2015
1	Neoplasm Metastasis (Metastasis) 04/2015
1	Prostatic Neoplasms (Prostate Cancer) 04/2015
1	Carcinogenesis 11/2011
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 01/2011
1	Uterine Cervical Dysplasia 10/2009
1	Squamous Intraepithelial Lesions 10/2009
1	Hemorrhage 11/2007
1	Endometriosis 11/2007
1	Dysmenorrhea (Menstrual Pain) 11/2007
1	Ovarian Cysts (Ovarian Cyst) 11/2007
1	Endometrioid Carcinoma 01/2007
1	Cystadenoma 01/2002
1	Cystadenocarcinoma 01/2002

Drug/Important Bio-Agent (IBA)

12	ParaffinIBA 05/2013 - 01/2002
11	Formaldehyde (Formol)FDA Link 05/2013 - 01/2002
5	AntibodiesIBA 11/2011 - 01/2004
3	Histones (Histone)IBA 03/2015 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 03/2015 - 01/2004
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2012 - 04/2005
3	ErbB Receptors (EGF Receptor)IBA 01/2011 - 10/2007
3	Galectin 3 (LGALS3)IBA 07/2008 - 01/2003
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2015 - 04/2015
2	VimentinIBA 07/2013 - 01/2010
2	SurvivinIBA 11/2012 - 11/2011
2	EnzymesIBA 11/2012 - 04/2005
2	Monoclonal AntibodiesIBA 10/2007 - 01/2006
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2007 - 01/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2004 - 01/2002
2	trioctyl phosphine oxide (TOPO)IBA 01/2004 - 08/2002
2	Hematoxylin (Haematoxylon)IBA 01/2002 - 01/2002
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2002 - 01/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015
1	Uric Acid (Urate)IBA 12/2015
1	CholesterolIBA 12/2015
1	C-Reactive ProteinIBA 12/2015
1	Triglycerides (Triacylglycerol)IBA 12/2015
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 04/2015
1	Interleukin-6 (Interleukin 6)IBA 04/2015
1	Keratins (Keratin)IBA 07/2013
1	Biological ProductsIBA 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 04/2011
1	DesminIBA 01/2010
1	ChromatinIBA 01/2010
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 10/2009
1	N 30IBA 10/2009
1	Cyclin D1IBA 07/2008
1	Levonorgestrel (Plan B)FDA LinkGeneric 11/2007
1	Poly Adenosine Diphosphate RiboseIBA 04/2007
1	caspase-activated DNase inhibitorIBA 01/2007
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2004
1	Cellular Apoptosis Susceptibility ProteinIBA 01/2004
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2002
1	Alkaline PhosphataseIBA 01/2002
1	A-factor (Streptomyces)IBA 01/2002
1	Indicators and Reagents (Reagents)IBA 01/2002

Therapy/Procedure

1	Transurethral Resection of Prostate (TURP) 12/2015
1	Intrauterine Devices (Intrauterine Device) 11/2007
1	Contraception (Birth Control) 11/2007
1	Laparotomy 11/2007